Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization
- Conditions
- Tobacco Use Cessation
- Registration Number
- NCT02099097
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
The purpose of this study is to develop and test a web-based game called Quit It that is designed to help smokers who have quit smoking cope with any smoking urges they may have. The purpose of the game is to help people quit and stop people from smoking again.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Age ≥ 18 years old
- English-speaking
- Cancer (solid tumor) diagnosis or mass suspicious of cancer within past six months as per clinical judgment
- Cancer treatment expected plan to include hospitalization for surgical treatment for at least 2 days at MSKCC as per the patients clinical team
- Referred to MSK's Tobacco Cessation Program
- Patient-reported cigarette use within the past 30 days
- Have sufficient sensory acuity (i.e., auditory, visual) and manual dexterity to use a computer game as per judgment of clinician or consenting professional
- Can be reached by telephone
- Distant metastatic disease at the time of enrollment
- Major psychiatric illness or cognitive impairment that in the judgment of the investigator would preclude study participation
- Any patients who are unable to comply with the study procedures as determined by the study investigators
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method quitting smoking self-efficacy 1 year as measured by the Confidence Questionnaire to assess changes in confidence in being able to resist urges to smoke across everyday situations.
- Secondary Outcome Measures
Name Time Method efficacy of the game 1 year on smoking abstinence and relapse prevention. We will examine time to smoking relapse following hospitalization, measured as part of the follow-up Smoking Status 1 month following enrollment. We will also biochemically verify 7-day point prevalence smoking abstinence at the 1 month follow-up assessment.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States
Memorial Sloan Kettering Cancer Center🇺🇸New York, New York, United States